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HIV-1 Integration in the Human Genome
Favors Active Genes and Local Hotspots
maximal DNA distortion were particularly favored for
integration (Pruss et al., 1994a, 1994b), probably be-
cause integrase distorts its DNA substrates during the
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wrapping of DNA in nucleosomes alone does not inhibit10010 North Torrey Pines Road
La Jolla, California 92037 integration.
In cells, nucleosomal DNA is assembled into higher-3 Department of Family/Preventive Medicine
School of Medicine order chromatin, with unknown consequences for inte-
gration site selection. Studies in vivo can potentiallyUniversity of California, San Diego
San Diego, California 92093 address the influence of chromatin on integration tar-
geting, but previous studies have led to diverse and
sometimes conflicting proposals (for reviews see Bush-
man, 2001; Coffin et al., 1997). Early studies suggestedSummary
that integration may be favored near DNase I hypersen-
sitive sites (Panet and Cedar, 1977; Rohdewohld et al.,A defining feature of HIV replication is integration of
the proviral cDNA into human DNA. The selection of 1987; Vijaya et al., 1986) or active genes (Mooslehner
et al., 1990; Scherdin et al., 1990). However, a recentchromosomal targets for integration is crucial for effi-
cient viral replication, but the mechanism is poorly report suggested that high-level transcription actually
interfered with integration by avian leukosis virus (ALV)understood. Here we describe mapping of 524 sites
of HIV cDNA integration on the human genome se- (Weidhaas et al., 2000). Heterochromatic regions of
chromosomes have been proposed to be disfavored forquence. Genes were found to be strongly favored as
integration acceptor sites. Global analysis of cellular HIV integration in cell culture (Carteau et al., 1998), but
a study of HTLV integration sites from patients did nottranscription indicated that active genes were prefer-
ential integration targets, particularly genes that were see this trend (Leclercq et al., 2000). Another early study
suggested that ALV strongly favored integration at hot-activated in cells after infection by HIV-1. Regional
hotspots for integration were also found, including spots comprised of specific base pairs in an avian ge-
nome (Shih et al., 1988), but a reexamination of thesea 2.4 kb region containing 1% of sites. These data
document unexpectedly strong biases in integration sites using another method did not reveal such a strong
bias (Withers-Ward et al., 1994). Many of the above stud-site selection and suggest how selective targeting pro-
motes aggressive HIV replication. ies were limited by analysis of relatively few integration
events and none analyzed integration site placement on
a complete genome sequence.Introduction
Here we report an analysis of integration target selec-
tion by HIV-1 in the human genome. We infected a hu-The early steps of retroviral replication involve reverse
transcription of the viral RNA genome to make a cDNA man lymphoid cell line with HIV or an HIV-based vector
and cloned 524 junctions between viral and cellular DNA.copy, then integration of that cDNA copy into a chromo-
some of the host cell. The integration reaction requires The sequences were then determined and mapped on
the human genome sequence. As a control, 111 sitesspecific sequences at the ends of the viral cDNA, which
bind the viral-encoded integrase and other proteins to were generated by integration in vitro into naked human
DNA and their genomic distribution compared with theform preintegration complexes (PICs). The cellular DNA
sequences that serve as integration target sites, how- in vivo integration sites. Genes were clearly preferential
integration targets for the in vivo-targeted set but notever, show no strong primary sequence preferences.
Here we investigate targeting of integration in the cellu- for the in vitro control. Transcriptional profiling revealed
a strong correlation between gene activity and integra-lar chromosomes in vivo, where the target DNA is pack-
aged in chromatin, revealing strong biases imposed by tion targeting, particularly for genes that were active in
cells after infection with the HIV vector. Hotspots forthe in vivo environment.
Studies using integration in vitro have clarified factors integration were also detected, including a 2.5 kb region
that contained 1% of integration events. These datainfluencing integration site selection in simplified mod-
els. DNA binding proteins bound to target DNA can block reveal unexpected specificity in integration targeting by
HIV and begin to elucidate the mechanism of site choiceintegration by obstructing access of integration com-
plexes to target DNA (Bushman, 1994; Pryciak and Var- in vivo.
mus, 1992). In contrast, DNA bending proteins such as
nucleosomes can actually promote integration (Pruss Results
et al., 1994a, 1994b; Pryciak et al., 1992; Pryciak and
Varmus, 1992). On the nucleosome, the positions of Cloning Sites of HIV Integration
To investigate HIV integration targeting in the human
genome, we infected a human T cell line (SupT1) with4 Correspondence: bushman@salk.edu
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HIV or an HIV-based vector (Carteau et al., 1998; Follenzi Within genes, integration was favored in introns over
exons, likely a result of the greater size of introns com-et al., 2000), then isolated chromosomal DNA containing
integrated proviruses after 48 hr. The short time was pared to exons (Lander et al., 2001; Venter et al., 2001).
More detailed analysis was not attempted due to thechosen to minimize possible selection at the cellular
level due to integration, thus preserving the initial distri- incomplete information available on the structure of the
human genes. All targeted genes were predicted to bebution of sites (in this work, “site” is used to indicate
both a short sequence in the genome and that same transcribed by RNA polymerase II. There was no signifi-
cant correlation between the direction of viral transcrip-sequence flanking a provirus after integration). Purified
cellular DNA was cleaved with restriction enzymes, link- tion and the direction of transcription in genes that
hosted integration events (p  0.3 for the hypothesis ofers were ligated onto the DNA ends, and then sequences
were amplified with primers complementary to the linker correlation). Preliminary studies of integration sites in
human peripheral blood mononuclear cells also showedand the HIV cDNA end. DNA fragments containing junc-
tions between integrated HIV proviruses and cellular favoring of integration in genes, indicating that this ten-
dency is not unique to the SupT1 cell line studied hereDNA were then cloned and sequenced, yielding 524
different integration target sequences. (R. Mitchell, A.R.W.S., P.S., H.C., C.B., J.R.E., and F.B.,
unpublished data).As a control, integration products were generated in
vitro using naked genomic DNA from SupT1 cells as an
integration target. HIV preintegration complexes (PICs) Gene Activity and HIV Integration
were used as a source of integration activity (Brown et To investigate whether integration site selection was
al., 1987; Ellison et al., 1990; Farnet and Haseltine, 1990; influenced by transcriptional activity, we analyzed the
Hansen et al., 1999). PICs are replication intermediates SupT1 target cells by transcriptional profiling. RNA was
that can be isolated from infected cells and which con- harvested from SupT1 cells, labeled, and analyzed using
tain the viral cDNA, integrase, and other viral and cellular the Affymetrix U95A chip, which assays about 12,000
proteins (Bukrinsky et al., 1993; Farnet and Bushman, human genes. Of the 524 integration sites studied in the
1997; Gallay et al., 1995; Miller et al., 1997). PICs were in vivo population, 358 were in genes. Of those, 179
incubated with purified genomic DNA in vitro to allow were in genes that were assayed on the chip. The median
integration, then junctions between viral and cellular expression level of this group of genes, using the “aver-
DNA sequences were cloned and sequenced, yielding age difference” expression metric, was 1300. In con-
111 control integration sequences. Comparison of se- trast, the median for all the genes tested on the chip
quences generated by integration in vivo and in vitro was 700. For the in vitro control, only 35% of integration
allows possible biases due to the cloning protocol to sites were in genes (39 total), and only 18 of these were
be detected and highlights the effects of the intracellular assayed by the chip. The median average difference for
environment. this group was 616, close to the chip average.
These data suggested that transcription may be corre-
lated with favored integration, but a statistically rigorousHIV Integration Is Favored in Genes
We mapped the integration site sequences on the draft assessment was needed. All of the genes assayed by
the chip were divided into eight equal sets by relativehuman genome (Lander et al., 2001; Venter et al., 2001)
and asked (1) whether integration sites were correlated expression level in SupT1 cells. The genes targeted for
integration in vivo were then distributed into the samewith features mapped on the genome sequence, and
(2) whether integration sites were correlated with each “bins” and summed (Figure 2A). A strong trend was
found, in which genes hosting integration events wereother. The distribution of integration sites is shown
mapped on the human chromosomes in Figure 1. scarce in the lowest expression categories and enriched
in the highest categories (p  0.0001), indicating thatAnalysis of the placement of the integration sites
made by infection in vivo revealed that 69% resided in transcriptional activity correlates with integration site
selection. No significant trend was seen with the controltranscription units, a highly significant departure from
random placement (p  1011; a detailed description of in vitro integration sites, though the number analyzed
was lower.our statistical methods is available in the Supplemental
Data at http://www.cell.com/cgi/content/full/110/4/521/ We next assessed the correlation between integration
site placement and gene activity after infection of SupT1DC1). The populations of sites made with HIV-1 or the
HIV-derived vector could be analyzed separately, re- cells with the HIV vector. Cells are known to change
their transcriptional programs within 30 min after HIVvealing that each favored integration in genes (86% for
HIV-1 analyzed alone and 67% for the HIV-based vector; infection (Arendt and Littman, 2001; Corbeil et al., 2001;
Geiss et al., 2000), well before integration can take placethe difference is not statistically significant). For the con-
trol in vitro integration sites, 35% were in transcription (Butler et al., 2001). How infection initiates signaling and
leads to transcriptional changes is unclear. Some possi-units. The human genome is about 33% transcription
units (Lander et al., 2001; Venter et al., 2001), so the bilities include: (1) signaling due to engagement of CD4
and coreceptor by the viral envelope protein (Davis et al.,frequency of integration in genes in vitro is not signifi-
cantly different from the frequency expected for random 1997; Popik and Pitha, 2000), (2) activation of signaling
pathways by nef (Simmons et al., 2001), (3) activationplacement of sites (p  0.76). For the in vivo population
of integration sites, gene-dense regions and gene-rich of the interferon response (Corbeil et al., 2001), (4) acti-
vation of the stress response (Corbeil et al., 2001), and (5)chromosomes were also favored for integration, and
even those integration events outside of genes tended activation of the DNA damage response accompanying
synthesis of the unintegrated viral DNA (Temin et al.,to be in gene-rich regions. No functional class of genes
was obviously favored or disfavored for integration. 1980; Li et al., 2001).
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Figure 1. Sites of HIV-1 cDNA Integration in the Human Genome
Locations of chromosomal sequences matching HIV-1 integration site clones are shown as “lollipops” above the linear chromosomes. Purple
indicates HIV-1; red, HIV-based vector; and green, PIC (in vitro control). The human chromosomes are shown numbered. For each chromosome,
the color of the dashes on the upper bar indicates integration within genes (gold) or outside genes (gray). The lower bar indicates relative
gene density, with more-gene-dense regions shown as a more intense red. Centromeres are shown by the gray rectangles. Karyotype analysis
showed that the Y chromosome is not present in the SupT1 cells studied and the representation of chromosomes was roughly equal in the
cells analyzed (data not shown).
We thus asked whether the infection-induced pattern tegration site placement and transcription in infected
cells that was even stronger than the correlation withof transcription correlated more strongly with integration
than the uninfected cell pattern (Figure 2B). Cells were data from transcription in uninfected cells (p  0.0001).
The difference in the trends in infected versus uninfectedinfected with the HIV-based vector, RNA was harvested
48 hr later (the same time at which DNA was harvested cells was also highly significant (p 0.0001). The scatter
plot in Figure 2C highlights the differences in gene activ-for cloning of integration sites), and samples were as-
sayed using the Affymetrix U95A chip. Extensive tran- ity between infected and uninfected cells. This analysis
illustrates that the average expression rank is increasedscriptional changes were seen after infection, with about
8% of genes showing a 2-fold or greater increase in for genes targeted for integration compared to the
SupT1 population as a whole and that the average ex-expression and 9% showing as similar decrease. Genes
involved in transcription, DNA repair, signaling, and me- pression rank for targeted genes is higher in infected
cells than in uninfected cells.tabolism were notable among those affected. Compari-
son with a previous study of transcription in CEM cells
infected by replication-competent HIV-1 (Corbeil et al., Regional Hotspots for HIV Integration
Regional hotspots for integration were also detected.2001) allowed a set of genes to be identified that were
affected in both experiments, possibly representing a The most favored region found was an intergenic locus
in chromosome 11q13, which contained five indepen-“core” set of genes responding to the infection process
(a list of these genes is available in the Supplemental dent integration sites within 2.4 kb (Figure 3A). To docu-
ment clustering in the full data set, we compared theData at http://www.cell.com/cgi/content/full/110/4/
521/DC1). distribution of lengths of DNA segments between inte-
gration sites to the distribution expected under homoge-Statistical analysis revealed a correlation between in-
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Figure 2. Genes Targeted for Integration In
Vivo Analyzed by Transcriptional Profiling
(A) Analysis of expression levels of genes tar-
geted for integration in uninfected SupT1
cells. Expression levels were scored by the
average difference value as defined in the
Affymetrix Microarray Suite 4.0.1 software
package. The roughly 12,000 genes assayed
were distributed into eight equal “bins” (1500
genes per bin) by relative expression levels.
That is, each bin is defined by a span of aver-
age difference values calculated to include
one-eighth of all genes assayed on the chip.
The bin with the lowest average expression
is at the left and the highest at the right. Genes
used as integration targets were then distrib-
uted into the same bins based on their ex-
pression levels and summed. The vertical
axes indicate the numbers of genes hosting
integration events in each bin. The horizontal
line indicates the value expected with no bias,
which would be reached if one-eighth of all
the genes analyzed were placed in each bin.
(B) The same as in (A) but using data from
cells analyzed 48 hr after infection with the
HIV vector. The trends in (A) and (B) show a
highly significant difference (p  0.0001).
(C) Scatter plot comparing results from unin-
fected and infected cells. All 12,000 genes
tested in each experiment were ranked by
expression level. Each gene is shown as a
gray point, with the position determined by
the rank in the uninfected cell data (horizontal
axis) and the infected cell data (vertical axis).
Red circles indicate genes used as integra-
tion targets. Triangles indicate the grand av-
erage for all genes and for genes hosting inte-
gration events. The average expression level
of targeted genes is displaced to the right and
upward of the average of all genes, indicating
that gene activity was correlated with integra-
tion targeting both before and after infection.
The average for genes hosting integration
events is above the diagonal that designates
equal expression in both experiments, indi-
cating that integration is favored in those
genes that increased in expression after in-
fection.
neous (random) integration (Figure 3B). The in vivo popu- activation process itself may promote formation of re-
gional hotspots, though other factors likely contributelation of integration sites contained many more short
intersegment distances than expected, indicative of as well.
clustering. No significant clustering was found in the in
vitro control data. HIV Integration and Human Endogenous
Retroviruses (HERVs)To assess the relationship between gene activity and
favored loci, we cataloged and analyzed regions of100 Human endogenous retrovirus (HERV) sequences,
which account for 8% of the human genome (Lander etkb containing three or more integration sites. This
yielded seven regional hotspots, four of which contained al., 2001), are found predominantly in intergenic regions
(Smit, 1999). Genomic positions of human endogenousa gene (data not shown). High local gene density corre-
lated with all regional hotspots, providing a partial expla- retroviruses are negatively correlated with sites of HIV
integration (p  0.0002 versus p  0.24 for the in vitronation for the bias. Regional hotspot function was further
probed by quantifying expression of the four targeted control; Table 1). For HIV integration sites within genes,
HERV sequences are very infrequent at the site of inte-genes by fluorescence-monitored RT-PCR. The tar-
geted genes in all four cases were found to be active, gration, while for integration sites outside of genes, the
trend is much weaker (data not shown). Thus, the nega-and all increased in activity after infection by 2- to 3-fold
(data not shown). Four control genes not targeted for tive correlation between HERVs and HIV integration sites
is largely explained by favoring of HIV integration inintegration were tested similarly and found not to in-
crease in activity (p  0.03, Fisher’s exact test). These genes.
HERVs and HIV proviruses located within genes alsodata support the conjecture that some aspect of the
HIV Integration in the Human Genome
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Figure 3. Regional Hotspots for Integration
(A) The 11q13 regional hotspot. Integration
sites are shown at the top, with the direction
of HIV transcription indicated by the arrow.
The upper coordinate indicates the base po-
sition (August 1, 2001, freeze of the sequence,
UCSC) and local repeated sequences. The
lower coordinate indicates nearby genes.
(B) Analysis of integration site spacing on the
human genome. Integration site clustering
was assessed by comparing the spacing be-
tween integration sites to the same number
of uniformly distributed (random) sites. Dis-
tances between sites are collected in eight
length “bins,” with the shortest intersite
lengths to the left and the longest to the right.
To highlight differences between the experi-
mental data sets and the calculated random
data set, the data are plotted as the ratio of
the observed count for each spacing cate-
gory divided by the expected count under
uniform distribution. The distances between
sites and the numbers of sites are as indi-
cated below the bar graph. Red indicates in
vivo integration sites and yellow the in vitro
control. If no clustering of integration sites
was detected, then the observed would equal
the expected, and the bar height would be 1
(dotted line); the greater height of the red bars
at shorter distances between sites indicates
clustering.
differ by their orientation relative to gene transcription. tion sites (Smit, 1999). In contrast, no significant direc-
tional bias is seen for integrated HIV proviruses in genesThe minority of HERV sequences found within genes
are predominantly in reverse orientation relative to the (p  0.3 for the hypothesis of correlation). The modern
HERV distribution probably resulted from selectiondirection of gene transcription, which is expected to
prevent transcription termination at HERV poly(A) addi- against host genomes containing proviruses that inter-
Table 1. Chromosomal Features Associated with HIV-1 Integration Sites
Chromosomal Percent in Percent at In Vivo Percent at In Vitro
Feature Human Genome Integration Sites Integration Sites
Transcription units 33%a 69% (p  0.0001) 35% (p  0.76)
SINES
Alu 10.6% 15.9% (p  0.001) 13.2% (p  0.43)
MIR 2.2% 0.7% (p  0.03) 0.8% (p  0.47)
DNA elements 2.8% 2.2% (p  0.46) 0.8% (p  0.29)
LTR elements (HERV) 8.3% 3.7% (p  0.0002) 6.6% (p  0.61)
LINE 20% 17.0% (p  0.10) 16.5% (p  0.4)
Satellite
alpha Satellite UN 0.4% 1.7%
beta Satellite UN 0% 1.7%
The integration sites studied included those mapped to unique locations on the genome and those in identifiable repeats. p values are for
comparison of each integration site population to the human genome.
Abbreviation: UN, unknown.
a Estimated value
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526
fered with gene function, accounting both for the accu- different levels, whereas the study presented here as-
sayed targeting by HIV genome-wide. Possibly the dif-mulation outside genes and the orientational bias. This
ferent experimental approaches emphasized differentcomparison emphasizes the different requirements for
aspects of target selection. For example, the tendencypersistence in the primate lineage characteristic of
seen in the HIV study might be due to favorable interac-HERVs versus aggressive replication by HIV.
tions between PIC components and transcription initia-
tion proteins, as suggested by the studies of yeast retro-HIV Integration and Other Repeated Sequences
transposons (Ji et al., 1993; Kirchner et al., 1995; BoekeHIV integration was favored in Alu elements (p  0.001),
and Devine, 1998). However, polymerase passage itselfpotentially because Alu elements are enriched in gene-
might actually disfavor integration, possibly by stericrich regions (Table 1; Lander et al., 2001; Stevens and
collision with PICs attempting integration, explaining theGriffith, 1996; Venter et al., 2001). No bias was seen in
ALV data. Alternatively, ALV may differ from HIV in itsfavor of LINE elements (contrary to Stevens and Griffith,
biases for chromosomal target sites. Further studies will1994). MIR elements were underrepresented at integra-
be needed to address these issues.tion sites in vivo for unknown reasons.
Integrating into active genes may have evolved toThe frequency of satellite sequences was lower in the
facilitate efficient HIV gene expression after infection.in vivo data set than in the in vitro set (p  0.012).
Verdin and coworkers have reported that integration ofSatellite DNA at centromeres and telomeres is known
HIV at different chromosomal loci correlates with quiteto be packaged in distinctive heterochromatin. As sug-
different levels of gene expression (Jordan et al., 2001).gested previously, wrapping of target DNA in hetero-
Differences could be attributed to the local chromatinchromatin probably disfavors integration (Carteau et al.,
environment—thus, integration targeting to active genes1998).
may be important for efficient expression of the HIVNone of the data on integration in repeated sequences
genome.for the control in vitro data set showed a significant
Some aspects of the molecular nature of regional inte-departure from the genome average (Table 1). Thus,
gration hotspots are suggested by our data. Regionalintegration in vitro apparently sampled the naked chro-
hotspots lie in regions enriched for active genes, indicat-mosomal target DNA without detectable biases. The
ing that those forces favoring integration in genes mayobservation of apparently random integration in vitro
favor integration in regional hotspots as well. For genesargues strongly against possible artifactual biases intro-
at 100 kb regions hosting three or more integrationduced during the isolation and analysis of integration
events, all were activated by infection with HIV, sug-sites. This finding provides important support for the
gesting further that the activation process itself maysignificance of the strong biases detected in the in vivo
be favorable. For example, proteins may bind to genesintegration data.
during the activation process that promote integration.
However, the 11q13 hotspot is in an intergenic region,Discussion
and the favoring of integration in gene-rich regions does
not fully account for the quantitative “risk” of serving as
We report that sites of HIV integration in the human
a regional hotspot, emphasizing that additional factors
genome are not randomly distributed but instead are
likely play a role.
enriched in active genes and regional hotspots. The
Eukaryotic retrotransposons are known that target Pol
availability of the human genome sequence was crucial I or Pol III transcribed genes for integration, but HIV
for this study, allowing a much more straightforward favors Pol II. Pol II genes are the most abundant class,
and quantitative analysis of integration site selection limiting the conclusions on targeting that can be drawn,
than has been possible previously. Going forward, as but there clearly is not a dominant bias in favor of Pol
new chromosomal features are mapped onto the ge- I or Pol III genes for HIV. These differences in targeting
nome sequence, it will be possible to assess their possi- reflect differences in retroelement replication strategies.
ble influence on HIV integration by comparison with the The Ty1–4 retrotransposons of Saccharomyces cerevis-
data set reported here. iae integrate predominantly upstream of Pol III tran-
How does gene activity favor integration? Integration scribed genes, which are benign sites because Pol III
may be promoted by increased chromatin accessibility transcription is not disrupted by integration (Boeke and
in transcribed regions, thereby removing inhibitory ef- Devine, 1998). Similarly, the R1 and R2 non-LTR retro-
fects of an unfavorable chromatin environment. Alterna- transposons of insects target Pol I transcription units,
tively, integration may be promoted at active genes by which are again benign targets because the ribosomal
favorable interactions between PICs and locally bound genes are highly repeated (Burke et al., 1993). The Ty,
transcription factors, as has been suggested for integra- R1, and R2 elements maintain evolutionarily stable rela-
tion targeting by yeast retrotransposons (Ji et al., 1993; tionships with the host organism. HIV, in contrast, tar-
Kirchner et al., 1995). A further possibility is that the gets Pol II transcribed genes, which may help maximize
intranuclear environment of active genes is conducive to gene expression but at the expense of increased toxicity
integration. Whether transcription promotes integration for the host. Consistent with this idea, HERV elements,
directly or is correlated indirectly is unclear. Our finding which have persisted long-term in the primate lineage,
of favored integration in active genes comes as a sur- have accumulated primarily in benign sites outside
prise, since the prevailing view in the field has been that genes, and those HERVs that are in genes are in the
active transcription disfavors integration (Weidhaas et antisense orientation, thereby avoiding termination of
al., 2000). The Weidhass study, however, examined inte- gene transcription at HERV polyA addition sites (Smit,
1999).gration by ALV into a single model gene expressed at
HIV Integration in the Human Genome
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site sequences in the human genome have been deposited in Gen-The findings reported here suggest possible means
Bank (accession numbers BH609398–BH610085).for optimizing retrovirus-based technology. Retrovi-
ruses are widely used as insertional mutagens (Gaiano
Preparation of the Control Population
et al., 1996; Hartung et al., 1986; Zijlstra et al., 1989), so of In Vitro Integration Sites
mutagenic spectra might be widened if retroviruses with Purification of vector-derived HIV PICs used for the in vitro control
different target preferences can be identified. Recent was carried out as described (Hansen et al., 1999). In vitro integration
was achieved by incubating 250 l of PIC extract with 1 g ofstudies raise the possibility that ALV may have a different
SupT1 genomic DNA for 45 min at 37C. The integration productintegration preference than does HIV—if confirmed this
was recovered by incubating with proteinase K in 0.5% sodiummight be exploited for improved mutagenesis. The
dodecyl sulfate followed by extraction with phenol-chloroform and
safety of retroviral vectors in human gene therapy may ethanol precipitation. Cloning, sequencing, and analysis were as for
be increased by taking into account the integration tar- the in vivo integration site population.
get preferences described here. For example, data on
preferred integration sites could guide the choice of Microarray Analysis
RNA was harvested from SupT1 cells in log phase growth. For thegene-delivery vectors to minimize possible toxicity from
analysis of infected cells, infections were carried out with the HIV-integration and inform surveillance for possible malig-
based vector (stocks were generated by transfection as in Kafri etnancy due to integration at characteristic hotspots.
al., 1999; Hansen et al., 1999; Follenzi et al., 2000) at a multiplicity
of 1, and RNA was harvested 48 hr later. Labeling of RNA was
performed as described by Affymetrix (Santa Clara, CA). Ten micro-
Experimental Procedures
grams of cRNA were used per Affymetrix HU95A array, which assays
about 12,000 human transcripts (specifically 12,625 transcripts, but
Cloning Sites of HIV-1 Integration
including some duplicates and controls). Two chips were used for
Infection was carried out with a VSV-G pseudotyped HIV vector
each experimental condition and the average used for subsequent
(multiplicity of infection about 1 as determined by quantitative Alu-
analysis (using GeneSpring.4.0, Silicon Genetics, Redwood City,
PCR) (Butler et al., 2001). The HIV-vector particles used were pro-
CA). For the in vivo integration sites, we analyzed 179 integration
duced from the cell line SODk1CG2 (described in Kafri et al., 1999;
sites in 166 genes that were present on the chip (two genes had
Hansen et al., 1999). Note that the gag-pol component of the vector
three hits, and nine genes had two hits). For genes in the in vitro
system used (pPTK) encoded all of the HIV-1 auxiliary genes (e.g.,
set, 18 integration sites could be analyzed, the low number being
vif, vpr, vpu, nef, tat, rev), so any effects of these on integration
due to the relatively lower frequency of integration in genes the in
targeting were maintained in vector infections. The HIV-1 virus
vitro collection. Six genes analyzed on the chips were also tested
stocks used were derived by transfection of a plasmid encoding
by quantitative PCR, which showed good agreement with data from
the R9 strain (Carteau et al., 1998; Swingler et al., 1997). Infected
transcriptional profiling. Raw data is available upon request.
cell DNA was purified using the DNeasy Tissue Kit (Qiagen, Valencia,
CA) and cleaved with restriction enzymes that do not cut within
Statistical Analysisthe HIV-based vector genome (AvrII, SpeI, and NheI). Linkers were
A detailed description of the statistical methods used in this study isligated onto the cleaved DNA and sequences were amplified using
available as Supplemental Data at http://www.cell.com/cgi/content/one primer that bound to the linker DNA and one that bound to the
full/110/4/521/DC1.HIV cDNA. PCR products were diluted 1:1000 and amplified with
nested primers, and then amplification products were gel-isolated.
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